Recent

% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

dannytheinvestor 1 post  |  Last Activity: May 18, 2015 1:20 PM Member since: Apr 5, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • dannytheinvestor by dannytheinvestor May 18, 2015 1:20 PM Flag

    Long here.

    Much respect to Betonbio, Trader 388 and the other longs here.

    I'm thinking of taking out a loan to purchase more SGYP- already own 3k shares but opportunity calls. Just wanted to get some opinions about the potential patent weakness that user Frontiers brought to attention on investment hub. The concern is that Synergy's patent on composition is only based on a single amino acid modification and if discovered to happen in nature will invalidate their patent on Plecanatide.

    The article's title is "Plecanatide versus Linaclotide : Impending Patent Disaster for the Synergy Partner" and it is a couple pages long.

    Thoughts?

    Sentiment: Buy

TSRX
13.630.00(0.00%)Sep 11 4:00 PMEDT